| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006489185 |
| P356 | DOI | 10.1186/S40942-015-0010-Y |
| P932 | PMC publication ID | 5088471 |
| P698 | PubMed publication ID | 27847602 |
| P5875 | ResearchGate publication ID | 282556445 |
| P50 | author | Rohan Merani | Q57073732 |
| P2093 | author name string | Alex P Hunyor | |
| P2860 | cites work | Severe cutaneous aspergillosis in a premature neonate linked to nonsterile disposable glove contamination? | Q44919483 |
| Vitreous wick syndrome--a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. | Q44926672 | ||
| Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics | Q44950647 | ||
| The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections | Q44972000 | ||
| Pegaptanib for neovascular age-related macular degeneration | Q45206481 | ||
| Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents | Q45233247 | ||
| Reducing the risk of endophthalmitis after intravitreous injection | Q45250960 | ||
| Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery | Q45265014 | ||
| Bilateral simultaneous intravitreal injections in the office setting | Q45761367 | ||
| Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway | Q45817741 | ||
| Use of face masks by non-scrubbed operating room staff: a randomized controlled trial | Q45836264 | ||
| Survey of intravitreal injection techniques among retinal specialists in the United States. | Q45924632 | ||
| A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. | Q45980425 | ||
| The shouting surgeon as a possible source of endophthalmitis. | Q45992175 | ||
| Use of a Desmarres retractor for upper lid and lash isolation during intravitreal injections. | Q45998907 | ||
| Bacterial contamination of needle points after intravitreal injection. | Q46104031 | ||
| Povidone-iodine contact time and lid speculum use during intravitreal injection | Q46167796 | ||
| Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. | Q46211373 | ||
| Unsuspected glove perforation during ophthalmic surgery | Q46250929 | ||
| Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival | Q46351068 | ||
| Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes | Q46358666 | ||
| Reducing oral flora contamination of intravitreal injections with face mask or silence | Q46361015 | ||
| Lidocaine gel anesthesia for intravitreal drug administration | Q46420216 | ||
| Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting | Q46539029 | ||
| Assessment of the risk of needlestick injuries associated with intravitreal injections | Q46605483 | ||
| Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting | Q46711305 | ||
| Comparison in effectiveness of sterilization between chlorhexidine gluconate and povidone-iodine | Q46719916 | ||
| Evaluation of the skin flora after chlorhexidine and povidone-iodine preparation in neurosurgical practice | Q46740552 | ||
| Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. | Q46779481 | ||
| Surgical hand antisepsis to reduce surgical site infection | Q24242124 | ||
| What happened to the streptococci: overview of taxonomic and nomenclature changes | Q24535684 | ||
| Iodine allergy: an oyster without a pearl? | Q28249734 | ||
| The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed | Q28269171 | ||
| Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections | Q28282900 | ||
| Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors | Q28304030 | ||
| Defining unnecessary disinfection procedures for single-dose and multiple-dose vials | Q30465316 | ||
| Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials | Q33518324 | ||
| Use of retinal procedures in medicare beneficiaries from 1997 to 2007. | Q33715288 | ||
| Volume and composition of reflux after intravitreal injection. | Q33786453 | ||
| Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis. | Q33834598 | ||
| Streptococcus salivarius meningitis case strain traced to oral flora of anesthesiologist | Q33963657 | ||
| Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration | Q34043286 | ||
| The health professional's role in preventing nosocomial infections | Q34109252 | ||
| Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection | Q34142940 | ||
| Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels | Q34471964 | ||
| Ocular applications of povidone-iodine | Q34637802 | ||
| Surgical hand preparation: state-of-the-art | Q35000201 | ||
| Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result | Q35050222 | ||
| Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents | Q35122314 | ||
| Evaluation of patients' experiences at different stages of the intravitreal injection procedure - what can be improved? | Q35500814 | ||
| Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study | Q35590521 | ||
| Experimental evaluation of chlorhexidine gluconate for ocular antisepsis | Q35640857 | ||
| Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate | Q35693314 | ||
| An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab | Q35697390 | ||
| The effects of injection site on the reflux following intravitreal injections | Q35850012 | ||
| Evolving guidelines for intravitreous injections | Q35918010 | ||
| Minimizing the risk of endophthalmitis following intravitreous injections | Q35922103 | ||
| Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment | Q36161606 | ||
| Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics | Q36371395 | ||
| National survey of the technique of intravitreal triamcinolone injection in the United Kingdom | Q36378901 | ||
| The importance and implications of aseptic techniques during regional anesthesia | Q36542293 | ||
| Re: Infectious endophthalmitis after intravitreal injection of antiangiogenic agents | Q42829481 | ||
| Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens | Q42841857 | ||
| Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections | Q42959347 | ||
| The use of surgical facemasks during cataract surgery: is it necessary? | Q43009333 | ||
| Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections | Q43012675 | ||
| Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. | Q43227769 | ||
| Experimental model of intravitreal injection techniques | Q43271722 | ||
| Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort | Q43280156 | ||
| The toxic effect of different concentrations of povidone iodine on the rabbit's cornea | Q43289068 | ||
| Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics | Q43409092 | ||
| Infection rates of wound repairs during Mohs micrographic surgery using sterile versus nonsterile gloves: a prospective randomized pilot study | Q43428068 | ||
| Reducing the risk of endophthalmitis following intravitreal injections | Q43488438 | ||
| Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture | Q43502584 | ||
| Cytotoxicity of chlorhexidine | Q43545465 | ||
| Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection | Q43563479 | ||
| The concentration of povidone-iodine for preoperative disinfection: relation to endophthalmitis incidence | Q43639085 | ||
| Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion | Q43832122 | ||
| Hibiclens keratopathy. A clinicopathologic case report | Q43878237 | ||
| A cloud adult: the Staphylococcus aureus-virus interaction revisited | Q43919244 | ||
| Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery | Q44203598 | ||
| Inadvertent use of chlorhexidine as intraocular irrigation solution | Q44316136 | ||
| Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous | Q44380775 | ||
| Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters | Q44845413 | ||
| Bacterial dispersal associated with speech in the setting of intravitreous injections. | Q44884209 | ||
| Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? | Q82903294 | ||
| Quantitative efficacy of alcohol-based handrub against vancomycin-resistant enterococci on the hands of human volunteers | Q82982101 | ||
| In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates | Q83137096 | ||
| Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections | Q83655239 | ||
| Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes | Q83738744 | ||
| [Intravitreal injections of medications in Germany. Contract situation and legal conditions] | Q83756313 | ||
| Comparison of surgical hand scrub and alcohol surgical hand rub on reducing hand microbial burden | Q84437676 | ||
| Endophthalmitis is not a "never event" | Q84712041 | ||
| Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study | Q84798533 | ||
| Endophthalmitis after intravitreal injection: the importance of viridans streptococci | Q84859038 | ||
| Health risk behaviors in insured and uninsured community health center patients in the rural US South | Q85422660 | ||
| Evolving fluoroquinolone resistance among coagulase-negative Staphylococcus isolates causing endophthalmitis | Q85643464 | ||
| Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome | Q86033187 | ||
| Changes in ocular flora in eyes exposed to ophthalmic antibiotics | Q86135884 | ||
| Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy | Q86758725 | ||
| Povidone-iodine for endophthalmitis prophylaxis | Q87294327 | ||
| Intravitreal injections: is there benefit for a theatre setting? | Q87388862 | ||
| Simultaneous bilateral endophthalmitis after immediate sequential bilateral cataract surgery: what's the risk of functional blindness? | Q87487419 | ||
| To the Editor | Q95356782 | ||
| Post-dural puncture bacterial meningitis | Q36548229 | ||
| Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection. | Q36743069 | ||
| Is a mask necessary in the operating theatre? | Q36806102 | ||
| Increased bactericidal activity of dilute preparations of povidone-iodine solutions | Q37291195 | ||
| Sterile versus non-sterile glove use and aseptic technique | Q37319068 | ||
| Acanthamoeba keratitis: diagnosis and treatment update 2009. | Q37574514 | ||
| Aerosolized alpha-hemolytic Streptococcus as a cause of knee sepsis after intra-articular injection: predisposing factors | Q37626376 | ||
| Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures. | Q37629647 | ||
| Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy | Q37637882 | ||
| Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes | Q37678429 | ||
| Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis | Q37704870 | ||
| Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia | Q37823154 | ||
| Bilateral intravitreal injection of antivascular endothelial growth factor therapy. | Q37824226 | ||
| Effect of reflux of drug during intravitreal anti-VEGF therapies on foveal thickness. | Q37862253 | ||
| Intravitreal injection technique | Q37879159 | ||
| Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration | Q37879167 | ||
| Reflux of drug during intra-vitreal anti-VEGF therapies | Q37951623 | ||
| Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. | Q37981565 | ||
| Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review | Q38026388 | ||
| Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? | Q38029593 | ||
| Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. | Q38079798 | ||
| Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center | Q38080716 | ||
| Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases | Q38094263 | ||
| Bimanual assisted eyelid retraction technique for intravitreal injections | Q38100945 | ||
| Antibacterial properties of 2% lidocaine and reduced rate of endophthalmitis after intravitreal injection | Q38150707 | ||
| Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center | Q38153634 | ||
| The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. | Q38154352 | ||
| No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting | Q38169539 | ||
| Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. | Q38173250 | ||
| Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review | Q38221085 | ||
| Intravitreal injection technique and monitoring: updated guidelines of an expert panel. | Q38285696 | ||
| Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. | Q38455708 | ||
| Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections | Q38484631 | ||
| Examination gloves as barriers to hand contamination in clinical practice | Q39407188 | ||
| Susceptibility of various microorganisms to chlorhexidine | Q40486735 | ||
| Absence of bacterial resistance to povidone iodine | Q41244839 | ||
| Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon | Q41590291 | ||
| Bilateral same-session intravitreal injections of anti-vascular endothelial growth factors | Q41649671 | ||
| The doctor and the mask: iatrogenic septic arthritis caused by Streptoccocus mitis | Q42270947 | ||
| Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask | Q42276004 | ||
| Intravitreal foreign body following intravitreal anti-VEGF injection: a case report | Q42446351 | ||
| Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery | Q46828631 | ||
| Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure. | Q46901031 | ||
| Vitreous penetration of topical moxifloxacin and gatifloxacin in humans | Q46935548 | ||
| Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes | Q47228284 | ||
| ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS. | Q47407746 | ||
| Endophthalmitis after anti-VEGF injections | Q47679278 | ||
| Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study | Q47778632 | ||
| Safety of bilateral intravitreal injections delivered in a teaching institution | Q47877482 | ||
| Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection | Q48016869 | ||
| Barrier protection capacity of flip-top pharmaceutical vials. | Q48019459 | ||
| Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections | Q48172217 | ||
| Gloved and masked--will gowns be next? The role of asepsis during neuraxial instrumentation | Q48678171 | ||
| Cotton-tip applicator lid retraction technique for controlled intravitreal injection | Q48861887 | ||
| Three cases of bacterial meningitis after spinal and epidural anesthesia | Q49154640 | ||
| Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits | Q50443696 | ||
| Population kinetics of the skin flora on gloved hands following surgical hand disinfection with 3 propanol-based hand rubs: a prospective, randomized, double-blind trial. | Q50471310 | ||
| Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use. | Q50653446 | ||
| Ecology of viridans streptococci in the oral cavity and pharynx. | Q50701852 | ||
| Trends over time and geographical variation in rates of intravitreal injections in England. | Q51012472 | ||
| Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. | Q51015828 | ||
| The use of 31-gauge needles and syringes for intraocular injections. | Q51158219 | ||
| Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. | Q51167353 | ||
| Face masks and spinal anaesthesia. | Q51671705 | ||
| Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department: a randomized controlled trial. | Q51708570 | ||
| Needle contamination in the setting of intravitreal injections. | Q53623881 | ||
| Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. | Q54017308 | ||
| Lack of effect of antibiotic resistance on susceptibility of microorganisms to chlorhexidine gluconate or povidone iodine. | Q54061386 | ||
| Prophylaxis of Endophthalmitis with Topical Povidone-iodine | Q54072118 | ||
| Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous. | Q54456225 | ||
| We congratulate the authors for publishing their data on bilateral consecutive intravitreal injections administered in their office | Q56896238 | ||
| Effects of povidone-iodine chemical preparation and saline irrigation on the perilimbal flora | Q67595700 | ||
| Postoperative wound infections and surgical face masks: A controlled study | Q67917927 | ||
| Tolerance of intravitreal povidone-iodine in rabbit eyes | Q68658234 | ||
| Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic | Q70099819 | ||
| Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas | Q71142882 | ||
| Chlorhexidine effects on corneal epithelium and endothelium | Q71258694 | ||
| Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva | Q71347745 | ||
| The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery | Q71697535 | ||
| Chemical preparation of the eye in ophthalmic surgery. I. Effect of conjunctival irrigation | Q71725371 | ||
| A natural history study of experimental Staphylococcus epidermidis endophthalmitis | Q72737381 | ||
| Inadvertent use of chlorhexidine instead of balanced salt solution for intraocular irrigation | Q73686781 | ||
| Investigation on the efficacy of povidone-iodine against antiseptic-resistant species | Q73950673 | ||
| Avoidance of the use of gloves during ophthalmic surgery | Q76469621 | ||
| Scrubbing for cutaneous procedures can be hazardous | Q78024245 | ||
| The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes | Q79885697 | ||
| Tunneled scleral incision to prevent vitreal reflux after intravitreal injection | Q80380938 | ||
| Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab | Q82129823 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 9 | |
| P577 | publication date | 2015-07-21 | |
| P1433 | published in | International Journal of Retina and Vitreous | Q50639750 |
| P1476 | title | Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review | |
| P478 | volume | 1 |
| Q91619673 | A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes |
| Q92709046 | Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service |
| Q90246923 | Anesthesia for Intravitreal Injection: A Systematic Review |
| Q89965825 | Bacillus S-Layer-Mediated Innate Interactions During Endophthalmitis |
| Q58784488 | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
| Q92156956 | Detection of Subclinical Diabetic Retinopathy by Fine Structure Analysis of Retinal Images |
| Q54069067 | How to prevent endophthalmitis after intravitreal injections. |
| Q94595599 | Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments |
| Q33571514 | Microbial flora and resistance in ophthalmology: a review |
| Q38827899 | Modeling intraocular bacterial infections |
| Q48515898 | Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties. |
| Q98665178 | Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity |
| Q54580141 | Povidone-iodine is still a premium antiseptic measure in ocular surgery. |
| Q90685302 | Prognostic utility of whole genome sequencing and polymerase chain reaction tests of ocular fluids in post-procedural endophthalmitis |
| Q38959185 | Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents. |
| Q33801647 | Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration |
| Q39261103 | Topical antibiotics and intravitreal injections |
Search more.